Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.










Sub-classes under this class:

Class Number Class Name Patents
514/14 12 to 15 peptide repeating units in known peptide chain 1,156
514/13 16 to 24 peptide repeating units in known peptide chain 1,207
514/19 2 peptide repeating units in known peptide chain 1,352
514/12 25 or more peptide repeating units in known peptide chain structure 5,904
514/18 3 or 4 peptide repeating units in known peptide chain 1,666
514/17 5 or 6 peptide repeating units in known peptide chain 1,125
514/16 7 or 8 peptide repeating units in known peptide chain 1,087
514/15 9 to 11 peptide repeating units in known peptide chain 1,423
514/9 Cyclopeptides 730
514/8 Glycoprotein (carbohydrate containing) 2,102
514/6 Heavy metal containing (e.g., hemoglobin, etc.) 461
514/3 Insulin or derivative 639
514/5 Iodine containing 44
514/7 Phosphorus containing 211
514/21 Produced by or extracted from animal tissue 2,400


Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next

Patent Number Title Of Patent Date Issued
7482002 Method of administering and using VEGF inhibitors for the treatment of prostate cancer Jan. 27, 2009
7482001 Method of administering and using VEGF inhibitors for the treatment of non small cell lung cancer Jan. 27, 2009
7479484 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity Jan. 20, 2009
7479480 Peptides that promote lipid efflux Jan. 20, 2009
7479479 CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses Jan. 20, 2009
7479478 Human parathyroid hormone modifications, preparation and use Jan. 20, 2009
7479283 Acellular pertussis vaccine comprising a combination of the 69 kDa and the filamentous haemagglutinin antigens of Bordetella pertussis Jan. 20, 2009
7479282 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof Jan. 20, 2009
7479281 Botulinum toxin for treating postherpetic neuralgia Jan. 20, 2009
7479275 Method of administering and using VEGF inhibitors for the treatment of colorectal cancer Jan. 20, 2009
7479274 Method of administering and using VEGF inhibitors for the treatment of pancreatic carcinoma Jan. 20, 2009
7479273 Method of administering and using VEGF inhibitors for the treatment of renal cell cancer Jan. 20, 2009
7479272 Method of administering and using VEGF inhibitors for the treatment of breast cancer Jan. 20, 2009
7476651 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis Jan. 13, 2009
7476650 Enzyme inhibition Jan. 13, 2009
7476649 Antiproliferative and antiviral proteins and peptides Jan. 13, 2009
7476648 Vessel embolic material comprising hydrogel and therapy with the use thereof Jan. 13, 2009
7476388 Composition comprising a gastrin/CCK receptor ligand and an EGF receptor ligand Jan. 13, 2009
7473682 Angiogenic peptides and uses thereof Jan. 6, 2009
7473679 Treatments employing neuronal exocytosis-inhibiting peptides Jan. 6, 2009
7473678 Platelet-derived growth factor compositions and methods of use thereof Jan. 6, 2009
7470674 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides Dec. 30, 2008
7470666 Use of Ulinastatin and its pharmaceutical composition for treating severe acute respiratory syndrome Dec. 30, 2008
7470662 Method of reducing the likelihood of implantation failure during an assisted reproduction in a female subject in a need thereof Dec. 30, 2008
7470661 Delivery of superoxide dismutase to neuronal cells Dec. 30, 2008
7470660 Treatment for dark adaptation Dec. 30, 2008
7470659 Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) Dec. 30, 2008
7470658 Methods for inhibiting tumor metastasis, and peptides useful therefor Dec. 30, 2008
7470428 Compositions and methods related to TIM-3, a Th1-specific cell surface molecule Dec. 30, 2008
7468350 Glue composition for lung volume reduction Dec. 23, 2008
7468193 Nutritional composition against side effects of chemotherapy or radiotherapy Dec. 23, 2008
7468189 Neuropathic pain treatment method Dec. 23, 2008
7465734 Methods and compositions for overcoming resistance to biologic and chemotherapy Dec. 16, 2008
7465710 Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm Dec. 16, 2008
7465707 Methods of treatment with TR10 polypeptides Dec. 16, 2008
7465706 GDF3 propeptides and related methods Dec. 16, 2008
7465705 Nogo receptor antagonists Dec. 16, 2008
7465703 Methods and kits useful for guiding osteoporosis related therapy Dec. 16, 2008
7462598 Antimicrobial theta defensins, analogs thereof, and methods of use Dec. 9, 2008
7462595 Methods for treating cancer-related fatigue Dec. 9, 2008
7462594 Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases Dec. 9, 2008
7462593 Compositions and methods for promoting angiogenesis Dec. 9, 2008
7462592 Compositions and methods for polynucleotide delivery Dec. 9, 2008
7462489 Methods for identifying and analyzing biomarkers from plasma-derived microparticles Dec. 9, 2008
7462472 Methods and compositions relating to anthrax pathogenesis Dec. 9, 2008
7462365 Microencapsulation and sustained release of biologically active polypeptides Dec. 9, 2008
7462357 Compounds and methods for treatment and diagnosis of chlamydial infection Dec. 9, 2008
7462350 Cancer treatments including administering IL-2 fusion proteins with modulated selectivity Dec. 9, 2008
7462349 Beta interferon for the treatment of chronic spinal cord injury Dec. 9, 2008
7459440 Ocular tear growth factor-like protein Dec. 2, 2008

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next










 
 
  Recently Added Patents
System and method of verification of analog circuits
Inducement of organogenetic tolerance for pancreatic xenotransplant
Method and system for calibrating laser profiling systems
Methods and systems for determining the reliability of transaction
Dual-leadframe multi-chip package and method of manufacture
System for providing access to playable media
Block polymers and their process of preparation
  Randomly Featured Patents
Method of screening candidate drugs for the treatment of leukemia
Projection optical apparatus for projecting a mask pattern onto the surface of a target projection object and projection exposure apparatus using the same
Toothbrush
Dimethylamide and cationic surfactant debonding compositions and the use thereof in the production of fluff pulp
Reactor inlet
Embedded PCB identification
Fluorinated benzotriazoles
Hair styling implement
Speaker
AL-1 neurotrophic factor treatments